Amifampridine and Trospium / Xanomeline: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Amifampridine
No brand names on recordTrospium / Xanomeline
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
You've been prescribed amifampridine along with Cobenfy (which contains xanomeline and trospium). One thing to know is that amifampridine can lower the threshold for seizures, meaning it can make seizures a bit more likely in some people. Combining it with this other medicine may add to that risk.
I want to be clear that this concern is theoretical, meaning it's based on how the drugs work rather than a lot of real-world reports. It's still worth taking seriously. The good news is your care team can watch for this and adjust things if needed. Keep taking both as prescribed and let your doctor or pharmacist know if you notice any unusual symptoms.
Effect: Additive reduction in seizure threshold with concomitant amifampridine and xanomeline/trospium (Cobenfy), yielding increased seizure risk.
- Mechanism: Unknown; amifampridine is a potassium channel blocker with dose-dependent seizure potential, and the combination is presumed additive. Neither agent's activation is the relevant issue here.
- Direction: Increased seizure risk (pharmacodynamic).
- Evidence: Theoretical; onset unspecified; severity major.
- Management: Assess baseline seizure risk before co-prescribing. If used together, monitor closely for seizure activity and consider dose individualization. Weigh alternatives in patients with a seizure history.
What happens
Increased risk of seizures
Interaction Deep Dive
When amifampridine is taken together with this drug, the likelihood of seizures may be elevated. If the two agents are going to be given at the same time, this risk should be taken into account1.
Why it happens (mechanism)
Unknown
How to manage this interaction
Your care team can manage this safely. Here is what that usually looks like:
- They will consider your personal seizure risk before using these two together, and may monitor you more closely if you take both.
- Your doses may need to be adjusted and individualized by your care team.
- In some cases they may consider an alternative, especially if you have a history of seizures.
What you should do: Keep taking both medicines exactly as prescribed unless told otherwise. Tell your pharmacist or doctor if you have any history of seizures, and report right away any unusual symptoms such as twitching, confusion, or a seizure.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Amifampridine and Trospium / Xanomeline together?
Taking amifampridine with Cobenfy (xanomeline/trospium) may raise the risk of seizures, so keep taking both as prescribed but have your care team monitor you and flag any seizure history or unusual symptoms. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Amifampridine and Trospium / Xanomeline interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Amifampridine and Trospium / Xanomeline interaction managed?
Your care team can manage this safely. Here is what that usually looks like: They will consider your personal seizure risk before using these two together, and may monitor you more closely if you take both. Your doses may need to be adjusted and individualized by your care team. In some cases they may consider an alternative, especially if you have a history of seizures. What you should do: Keep t… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Amifampridine or Trospium / Xanomeline need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: FIRDAPSE(R) oral tablets, amifampridine oral tablets. Catalyst Pharmaceuticals Inc (per manufacturer), Coral Gables, FL, 2018. DailyMed
Keep reading about Amifampridine
Keep reading about Trospium / Xanomeline
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist